Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2009 May;53(5):2223-4.
doi: 10.1128/AAC.00240-09. Epub 2009 Mar 2.

Posaconazole therapeutic drug monitoring: a reference laboratory experience

George R Thompson 3rd, Michael G Rinaldi, Gennethel Pennick, Sheryl A Dorsey, Thomas F Patterson, James S Lewis 2nd
Comment

Posaconazole therapeutic drug monitoring: a reference laboratory experience

George R Thompson 3rd et al. Antimicrob Agents Chemother. 2009 May.
No abstract available

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Distribution of serum posaconazole levels obtained by the Fungus Testing Laboratory, San Antonio, TX, from 26 December 2007 through 30 December 2008.
See this image and copyright information in PMC

Comment on

References

    1. Andes, D., A. Pascual, and O. Marchetti. 2009. Antifungal therapeutic drug monitoring: established and emerging indications. Antimicrob. Agents Chemother. 53:24-34. - PMC - PubMed
    1. Cornely, O. A., J. Maertens, D. J. Winston, J. Perfect, A. J. Ullmann, T. J. Walsh, D. Helfgott, J. Holowiecki, D. Stockelberg, Y. T. Goh, M. Petrini, C. Hardalo, R. Suresh, and D. Angulo-Gonzalez. 2007. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N. Engl. J. Med. 356:348-359. - PubMed
    1. FDA. Accessed 17 February 2009. Posaconazole. FDA briefing document. http://www.fda.gov/cder/foi/nda/2006/022003s000_NoxafilTOC.htm.
    1. Gubbins, P. O., G. Krishna, A. Sansone-Parsons, S. R. Penzak, L. Dong, M. Martinho, and E. J. Anaissie. 2006. Pharmacokinetics and safety of oral posaconazole in neutropenic stem cell transplant recipients. Antimicrob. Agents Chemother. 50:1993-1999. - PMC - PubMed
    1. Krishna, G., M. Martinho, P. Chandrasekar, A. J. Ullmann, and H. Patino. 2007. Pharmacokinetics of oral posaconazole in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease. Pharmacotherapy 27:1627-1636. - PubMed

LinkOut - more resources